XT
NEUP

XTX Topco’s Neuphoria Therapeutics NEUP Stock Holding History

XTX Topco’s Portfolio NEUP Stock Details NEUP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$101K Buy
+23,089
New +$111K ﹤0.01% 3530
2026
Q1 		– Sell
-12,008
Closed -$46.6K – 4541
2025
Q4 		$46.6K Buy
+12,008
New +$85.3K ﹤0.01% 2855
2024
Q3 		– Sell
-912
Closed -$8.39K – 2713
2024
Q2 		$8.39K Buy
+912
New +$9.93K ﹤0.01% 1706
2024
Q1 		– Sell
-986
Closed -$17.8K – 2418
2023
Q4 		$17.8K Buy
+986
New +$28.1K ﹤0.01% 1376

Other funds holding NEUP

LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SC
Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

XTX Topco's NEUP Position: Q2 2026 in Review

XTX Topco opened a new position in Neuphoria Therapeutics (NEUP) in Q2 2026: 23,089 shares worth $101K. The stake represents ﹤0.01% of the portfolio and ranks #3530 among its holdings. This is a return to the name: XTX Topco previously reported a position in NEUP as recently as Q4 2025.

XTX Topco first reported a position in NEUP in Q4 2023 and has held it in 4 quarters since. 22 funds tracked by Wall St. Rank hold NEUP as of Q2 2026.

  • XTX Topco held 23,089 shares of Neuphoria Therapeutics worth $101K as of Q2 2026.
  • Neuphoria Therapeutics was a new XTX Topco position in Q2 2026.
  • Neuphoria Therapeutics made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3530 holding.
  • XTX Topco first reported a position in Neuphoria Therapeutics in Q4 2023 and has held it in 4 quarters since.
  • 22 funds tracked by Wall St. Rank held Neuphoria Therapeutics as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.